Please login to the form below

Not currently logged in
Email:
Password:

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

boehringer-uday-boseBoehringer Ingelheim has named Eisai's Uday Bose as head of global marketing for its oncology business.

Taking up the role on August 1, Bose will lead marketing efforts for Boehringer's fledgling activities in cancer, which has become an increasingly important area for the company since the launch of its first oncology product Giotrif (afatinib) last year.

Since then Boehringer has also filed its second cancer product nintedanib for approval in lung cancer.

Bose's responsibilities include the long-term marketing plan for the cancer portfolio, as well as the development of global strategies for Boehringer's cancer products and guiding the launch and marketing of individual drugs.

Bose is currently head of the oncology business unit for the EMEA region at Eisai – a position he has held since 2010. His past experience include senior marketing roles at GSK's oncology business and product manager positions at Sanofi.

14th July 2014

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics